Adult population Paramax is indicated for the symptomatic treatment of migraine.
Paramax is indicated for the symptomatic treatment of migraine
Utility Therapeutics received approval from the FDA for Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus